Role of melatonin in carcinogenesis and metastasis: From mechanistic insights to intermeshed networks of noncoding RNAs-Reference-Cited by-同舟云学术

Role of melatonin in carcinogenesis and metastasis: From mechanistic insights to intermeshed networks of noncoding RNAs

Published:2024-05-15 Issue:4 Volume:42 Page:
ISSN:0263-6484
Container-title:Cell Biochemistry and Function
language:en
Short-container-title:Cell Biochemistry & Function

Author:

Lin Xiukun¹,Qureshi Muhammad Zahid²,Tahir Fatima³,Yilmaz Seher⁴,Romero Mirna Azalea⁵,Attar Rukset⁶,Farooqi Ammad A.⁷^ORCID

Affiliation:

1. College of Marine Sciences Beibu Gulf University Qinzhou Guangxi China

2. Department of Environment and Natural Resources, College of Agriculture and Food Qassim University Buraidah Saudi Arabia

3. Rashid Latif Medical University Lahore Pakistan

4. Department of Anatomy, Faculty of Medicine Yozgat Bozok University Yozgat Turkey

5. Facultad de Medicina, Universidad Autónoma de Guerrero Laboratorio de Investigación Clínica Acapulco Guerrero México

6. Department of Obstetrics and Gynecology Yeditepe University Hospital Istanbul Turkey

7. Institute of Biomedical and Genetic Engineering (IBGE) Islamabad Pakistan

Abstract

AbstractIn recent years, seminal studies have been devoted to unraveling the puzzling mysteries associated with the cancer preventive/inhibitory role of melatonin. Our current knowledge of the translational mechanisms and the detailed structural insights have highlighted the characteristically exclusive role of melatonin in the inhibition of carcinogenesis and metastatic dissemination. This mini‐review outlines recent discoveries related to mechanistic role of melatonin in prevention of carcinogenesis and metastasis. Moreover, another exciting facet of this mini‐review is related to phenomenal breakthroughs linked with regulation of noncoding RNAs by melatonin in wide variety of cancers.

Publisher

Wiley

Reference58 articles.

1. Intracellular Signaling Pathways Involved in the Cell Growth Inhibition of Glioma Cells by Melatonin

2. Influence of melatonin on invasive and metastatic properties of MCF‐7 human breast cancer cells;Cos S;Cancer Res,1998

3. Biological and clinical results of a neuroimmunotherapy with interleukin-2 and the pineal hormone melatonin as a first line treatment in advanced non-small cell lung cancer

4. The growth inhibitory action of melatonin on human breast cancer cells is linked to the estrogen response system

5. A phase II study of tamoxifen plus melatonin in metastatic solid tumour patients